PhaseBio

PhaseBio Highlights Real-World Bleeding, Surgery Data at American College of Cardiology’s Annual Scientific Session

MALVERN, PA — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today highlighted real-world evidence presented over …

PhaseBio Highlights Real-World Bleeding, Surgery Data at American College of Cardiology’s Annual Scientific Session Read More